Machine learning model helps drug discovery
Source: CC0 Public Domain

Machine learning model helps drug discovery

Tandem mass spectrometry is a powerful analytical tool used to characterize complex mixtures in drug discovery and other fields. Now, Purdue University scientists have created a new method of applying machine learning concepts to the tandem mass spectrometry process to improve the flow of information in the development of new drugs.

"Mass spectrometry plays an integral role in drug discovery and development," said Gaurav Chopra, an assistant professor of analytical and physical chemistry in Purdue's College of Science. "The specific implementation of bootstrapped machine learning with a small amount of positive and negative training data presented here will pave the way for becoming mainstream in day-to-day activities of automating characterization of compounds by chemists."

Chopra said there are two major problems in the field of machine learning used for chemical sciences. Methods used do not provide chemical understanding of the decisions that are made by the algorithm, and new methods are not typically used to do blind experimental tests to see if the proposed models are accurate for use in a chemical laboratory.

"We have addressed both of these items for a methodology that is isomer selective and extremely useful in chemical sciences to characterize complex mixtures, identify chemical reactions and drug metabolites, and in fields such as proteomics and metabolomics," Chopra said.

The Purdue researchers created statistically robust machine learning models to work with less training data—a technique that will be useful for drug discovery. The model looks at a common neutral reagent—called 2-methoxypropene (MOP) - and predicts how compounds will interact with MOP in a tandem mass spectrometer in order to obtain structural information for the compounds. "This is the first time that machine learning has been coupled with diagnostic gas-phase ion-molecule reactions, and it is a very powerful combination, leading the way to completely automated mass spectrometric identification of organic compounds," said Hilkka Kenttämaa, the Frank Brown Distinguished Professor of Analytical Chemistry and Organic Chemistry. "We are now introducing many new reagents into this method."

The Purdue team introduces chemical reactivity flowcharts to facilitate chemical interpretation of the decisions made by the machine learning method that will be useful to understand and interpret the mass spectra for structural information.

The work is published in Chemical Science.

Subscribe to our newsletter

Related articles

AI-enabled rapid diagnostic test for COVID-19

AI-enabled rapid diagnostic test for COVID-19

Scientists have developed an extremely rapid diagnostic test that detects and identifies viruses in less than five minutes.

Network medicine makes drug repurposing effective

Network medicine makes drug repurposing effective

Artificial intelligence can increase the effectiveness of drug repositioning or repurposing research.

A microfluidic chip system as alternative to animal experiments

A microfluidic chip system as alternative to animal experiments

Since mid-2019, the Fraunhofer IBMT has been developing an analysis platform as an alternative to animal experiments in drug development.

Using tumor-on-a-chip to find cancer drugs

Using tumor-on-a-chip to find cancer drugs

Researchers have developed a 'tumor-on-a-chip' that can better mimic the environment inside the body, paving the way for improved screening of potential cancer fighting drugs.

Smart microscope adapts to diagnose infectious diseases

Smart microscope adapts to diagnose infectious diseases

Using machine learning, a prototype microscope teaches itself the best illumination settings for diagnosing malaria.

Swimming 3D printed donuts deliver therapies inside body

Swimming 3D printed donuts deliver therapies inside body

Researchers have developed a way to 3D print custom microswimmers that can transport drugs and nanotherapeutic agents, as well as potentially manipulate tissue directly inside the body.

Turbo chip for drug development

Turbo chip for drug development

Scientists develop process that facilitates and accelerates chemical synthesis and biological screening by combining all steps on a chip.

Tracking cholera outbreaks with AI

Tracking cholera outbreaks with AI

Algorithms using data from antibody signatures in peoples’ blood may enable scientists to assess the size of cholera outbreaks and identify hotspots of cholera transmission more accurately than ever.

Machine learning predicts metabolism, helping drug developers

Machine learning predicts metabolism, helping drug developers

Scientists have developed machine learning algorithms that can predict yeast metabolism from its protein content.

Popular articles